Nonin Medical

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Nonin Medical sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).

18 total trials none currently recruiting 17 completed top decile by trial count

Nonin Medical: 18 sponsored US clinical trials, none currently recruiting.

Nonin Medical sponsors 18 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 17 completed. The most-studied condition in this pipeline is Elevated Levels of Carboxyhemoglobin and Methemoglobin, with 1 trials.

Top-decile sponsor footprint

Nonin Medical ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 76/100

17 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

How the Nonin Medical archive is shaped

18 indexed studies, none listed as recruiting (0% open); 17 completed (94%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Elevated Levels of Carboxyhemoglobin and Methemoglobin (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Nonin Medical: archived-pipeline peers nationwide

Peers matched on 18 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Nonin Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%10%20%30%40% Total trials Recruiting share Nonin MedicalADC Therapeutics S.A.Akros PharmaAO Clinical Investigation and Publishing DocumentationAO Innovation Translation Center10xBio22nd Century Group23andMe3-C Institute for Social Development
Nonin Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Nonin Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 18 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Nonin Medical page

18 registered trials is a research-attention snapshot, not an endorsement of Nonin Medical or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Nonin Medical pipeline card: 18 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.